{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:56:33Z","timestamp":1764402993592,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.vaccine.2020.06.015","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T01:07:43Z","timestamp":1594343263000},"page":"5718-5725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant series"],"prefix":"10.1016","volume":"38","author":[{"given":"Jennifer L.","family":"Oliver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Sadorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Boisnard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam","family":"Bhakthavalsala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saul N.","family":"Faust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul T.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1756-5668","authenticated-orcid":false,"given":"Adam","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.06.015_b0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/INF.0b013e318187d047","article-title":"Impact of a pentavalent combination vaccine on immunization timeliness in a state Medicaid population","volume":"28","author":"Happe","year":"2009","journal-title":"Pediatric Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.06.015_b0010","first-page":"506","article-title":"Combination vaccine use and vaccination quality in a managed care population","volume":"13","author":"Happe","year":"2007","journal-title":"Am J Managed Care"},{"key":"10.1016\/j.vaccine.2020.06.015_b0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/INF.0b013e31805d7f17","article-title":"Use of combination vaccines is associated with improved coverage rates","volume":"26","author":"Marshall","year":"2007","journal-title":"Pediatric Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.06.015_b0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.inf.0000222413.47344.23","article-title":"The use of combination vaccines has improved timeliness of vaccination in children","volume":"25","author":"Kalies","year":"2006","journal-title":"Pediatric Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.06.015_b0025","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1542\/peds.2014-4102","article-title":"Immunogenicity, safety, and tolerability of a hexavalent vaccine in infants","volume":"136","author":"Marshall","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2020.06.015_b0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/INF.0000000000001406","article-title":"A phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at two, three, four and twelve months","volume":"36","author":"Vesikari","year":"2017","journal-title":"Pediatric Infect Disease J"},{"key":"10.1016\/j.vaccine.2020.06.015_b0035","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1016\/j.vaccine.2016.05.054","article-title":"A phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11\u201312 months","volume":"34","author":"Silfverdal","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.015_b0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/INF.0000000000001405","article-title":"Lot-to-lot consistency, safety, tolerability and immunogenicity of an investigational hexavalent vaccine in US infants","volume":"36","author":"Block","year":"2017","journal-title":"Pediatric Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.06.015_b0045","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/cdli.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2020.06.015_b0050","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1128\/CVI.00260-12","article-title":"Safety and immunogenicity of a meningococcal quadrivalent conjugate vaccine in five- to eight-year-old Saudi Arabian children previously vaccinated with two doses of a meningococcal quadrivalent polysaccharide vaccine","volume":"19","author":"Khalil","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.06.015_b0055","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1128\/jcm.26.1.72-78.1988","article-title":"Variable quantitation of Haemophilus influenzae type b anticapsular antibody by radioantigen binding assay","volume":"26","author":"Ward","year":"1988","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.06.015_b0060","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1128\/JCM.42.2.610-617.2004","article-title":"Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus","volume":"42","author":"Ismail","year":"2004","journal-title":"J Clin Microbiol"},{"year":"2003","series-title":"Modelling binary data","author":"Collett","key":"10.1016\/j.vaccine.2020.06.015_b0065"},{"key":"10.1016\/j.vaccine.2020.06.015_b0070","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CVI.00420-08","article-title":"Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom","volume":"16","author":"Southern","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.06.015_b0075","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.inf.0000227725.61495.c4","volume":"25","author":"Tejedor","year":"2006","journal-title":"Pediatric Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.06.015_b0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/adc.2005.076109","article-title":"Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-ital Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age","volume":"92","author":"Kitchin","year":"2007","journal-title":"Arch Disease Child"},{"key":"10.1016\/j.vaccine.2020.06.015_b0085","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.015_b0090","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.vaccine.2016.05.009","article-title":"Safety and immunogenicity of a CRM or TT conjugated meningococcal vaccine in healthy toddlers","volume":"34","author":"Bona","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.015_b0095","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.vaccine.2014.12.018","article-title":"Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule","volume":"33","author":"Ladhani","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.015_b0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1554","article-title":"Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial","volume":"350","author":"Pace","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2020.06.015_b0105","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/adc.2007.136036","article-title":"A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial","volume":"93","author":"Pace","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2020.06.015_b0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0140-6736(93)92298-8","article-title":"Antibody response to accelerated immunisation with diphtheria, tetanus, pertussis vaccine","volume":"342","author":"Ramsay","year":"1993","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.vaccine.2020.06.015_b0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/adc.67.4.475","article-title":"Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule","volume":"67","author":"Booy","year":"1992","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.vaccine.2020.06.015_b0120","doi-asserted-by":"crossref","first-page":"E232","DOI":"10.33321\/cdi.2014.38.38","article-title":"Surveillance of adverse events following immunisation in Australia, 2012","volume":"38","author":"Mahajan","year":"2014","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.vaccine.2020.06.015_b0125","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1128\/IAI.71.10.5549-5555.2003","article-title":"Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United Kingdom","volume":"71","author":"Borrow","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.06.015_b0130","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/14760584.5.6.851","article-title":"Long-term protection in children with meningococcal C conjugate vaccination: lessons learned","volume":"5","author":"Borrow","year":"2006","journal-title":"Exp Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:44:23Z","timestamp":1759401863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20307878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":26,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0264410X20307878"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant series","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}